Tim Andrews

EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases

Nneoma Duru, Marlies C. van der Goes, J. W. G. Jacobs et al. · Annals of the Rheumatic Diseases · 2013 · 270 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice

Marlies C. van der Goes, Johannes W. G. Jacobs, Maarten Boers et al. · Annals of the Rheumatic Diseases · 2010 · 193 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases

Marlies C. van der Goes, J. W. G. Jacobs, Maarten Boers et al. · Annals of the Rheumatic Diseases · 2009 · 136 citations

Medicine, Internal Medicine, Pharmacotherapy +11

Progressive exercise compared with best practice advice, with or without corticosteroid injection, for the treatment of patients with rotator cuff disorders (GRASP): a multicentre, pragmatic, 2 × 2 factorial, randomised controlled trial

Sally Hopewell, David J. Keene, Ioana R. Marian et al. · The Lancet · 2021 · 118 citations · Full text

Medicine, Orthopaedic Surgery, Rehabilitation Medicine +17

IL-1 receptor antagonist, anakinra, prevents myocardial dysfunction in a mouse model of Kawasaki disease vasculitis and myocarditis

Mark Gorelik, Youngho Lee, Masanori Abe et al. · Clinical & Experimental Immunology · 2019 · 73 citations · Full text

Life Sciences, Cardiology, Immunology +17